Debra Aron is speaking at the lecture to discuss the “ins and outs” of the qualitative elements for evaluating an alleged antitrust violation.
For more information on this event, click here.
A tale of two stakeholder groups in regulating healthcare AI
Despite significant spending on healthcare in the US, the industry is slow to adopt AI technology that can cut costs and improve efficiency. In this CPI...